Advertisement

Pfizer testing Omicron-based vaccine amid concerns about twin variant

Pfizer has started testing an Omicron-based COVID-19 vaccine to see if it can prevent infection and not only severe illness. The testing comes as researchers investigate an emerging variant described as Omicron’s twin.